Ocean Biomedical, Inc./DE

Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA) is a healthcare-focused blank-check company that completed its IPO in 2021. The SPAC announced a business combination with Ocean Biomedical, Inc., a Delaware-incorporated clinical-stage biopharmaceutical company developing therapies across oncology, infectious disease, and pulmonary arterial hypertension, on July 23, 2024. The transaction has since closed, bringing Ocean Biomedical into the public markets through the SPAC structure. Ocean Biomedical targets conditions with significant unmet medical need, operating at the intersection of biotechnology and pharmaceutical research. For full filing data, deal timelines, and analytics on AEHA and hundreds of other SPACs, sign up for complete access at SpacDesk.

SPAC Counterparty (1)